Novosanis has a long-standing relationship with the University of Antwerp. In 2013, Novosanis was founded as a spin-off company from the University of Antwerp.
CASUS, a urine-based solution to screen for cervical cancer Novosanis (Belgium) has been co-awarded a CASUS grant by Eurostars, a European Union (EU) program dedicated to supporting R&D...
This website uses cookies to help us give you the best experience when you visit our website. Read our cookie policy to learn more about the cookies we use. By continuing to use this website, you consent to the use of these cookies.
Novosanis
